Primary Sclerosing Cholangitis Market Driven By Rising Prevalence Of Inflammatory Bowel Disease Is Estimated To Reach US$ 2.79 Mn By 2030
Primary sclerosing cholangitis (PSC) is a progressive liver disease characterized by inflammation and scarring of the bile ducts that causes them to narrow. Symptoms include …